The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy.

In the era of highly active antiretroviral treatment (HAART), the prognosis of AIDS-related lymphomas might be similar to that of aggressive B-cell lymphomas in human immunodeficiency (HIV)-negative patients. In this study we found that HIV-infected patients with diffuse large B-cell lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone (CHOP) and HAART showed a similar response rate to chemotherapy, disease-free survival and overall survival as those of HIV-negative patients receiving CHOP.

[1]  R. Talamini,et al.  Outcome in patients with non-hodgkin lymphoma and with or without human immunodeficiency virus infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  U. Siebert,et al.  Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma , 2003, AIDS.

[3]  J. Esteve,et al.  Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study. , 2003, Haematologica.

[4]  É. Oksenhendler,et al.  Systemic Non‐Hodgkin Lymphoma in HIV‐Infected Patients With Effective Suppression of HIV Replication: Persistent Occurrence But Improved Survival , 2002, Journal of acquired immune deficiency syndromes.

[5]  O. Kirk,et al.  Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. , 2001, Blood.

[6]  U. Tirelli,et al.  Impact of HAART on the clinical management of AIDS-related cancers. , 2001, European journal of cancer.

[7]  J. Romeu,et al.  Influence of highly active anti‐retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome‐related non‐Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone , 2001, British journal of haematology.

[8]  B. Nathwani,et al.  Evolving characteristics of AIDS-related lymphoma. , 2000, Blood.

[9]  B. Gazzard,et al.  Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy. , 2000, Blood.

[10]  S. Franceschi,et al.  Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy. , 2000, AIDS.